July 03, 2019
1 min watch
Save

VIDEO: Surface Pharmaceuticals thrives in OCTANe environment

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

NEWPORT BEACH, Calif. — At OCTANe’s Ophthalmology Technology Summit, Kamran Hosseini, CEO of Surface Pharmaceuticals, discusses how the company has been working with OCTANe and the Visionary Venture Fund in developing its products for anterior segment surgery.